AstraZeneca presented trial data at the European Society of Cardiology Congress.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca presented trial data at the European Society of Cardiology Congress.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
European Society of Cardiology
non-profit knowledge-based professional association
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- BenzingaAstraZeneca's Latest Drug Offers Hope For Millions Battling Hard-To-Control Blood Pressure On Saturday, AstraZeneca Plc (NASDAQ:AZN) released full results from the BaxHTN Phase 3 trial evaluating bax